Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Ventro Corp.
In the course of validating disease targets or developing drugs, researchers need tissue samples from patients with specific types of diseases as well as from healthy patients.BioSample Inc., has an internet-enabled biological material procurement solution to the pharmaceutical/biotech community.
Despite the in silico research ideals of many genomicists, no one has yet found a way around the basic requirement for using human tissue in gene expression studies-a broad array of it, well characterized, from healthy and diseased patients, and from world populations at large. That's why start-ups, drug discovery firms and others are creating a new resource: biorepositories--banks of tissue samples and data to serve the diagnostic, pharmaceutical and tissue engineering industries. As providers of services and products to research-based companies, these companies believe they are operating in a market that ranges from $500 million to $5 billion.
From the politics of prescription drug coverage to the crash of the e-health sector, from biotech's market boom to the lackluster device IPO market, a look back at the most significant events of 2000.
While Ventro Corp. announces the closing of two of its B2B e-commerce businesses, its Broadlane business announces a major group purchasing agreement with Kaiser Permanente.
- Research, Analytical Equipment & Supplies